Copper is an essential trace element and is an integral part of many metabolic and other chemical processes in cells and tissues. Copper-based nanoparticles (CuNPs) have wide industrial and engineering applications, as catalysts, sensing materials, part of superconductors, storage systems, and phototermal / thermoelectric materials. In recent years, their potential use in biology and medicine has also contributed to the increased interest by scientific community. Unfortunately, many aspects of CuNP interactions with cells and tissues remain unknown. It is unclear if, in a living organism, CuNPs behave the same way as conventional metallic copper. Possible impact of CuNPs on the functioning of organs such as liver, kidney and brain is of particular concern. This concise review aims to cover recent research on potential CuNP toxicity, with the emphasis on neurotoxocity, nephrotoxicity and hepatotoxicity. Also, potential implications of CuNPs toxicity in fundamental and clinical medicine are discussed.
Introduction
Copper is a chemical element with numerous functions in living organisms. It belongs to the group of essential trace elements and is an integral part of many metabolic and other chemical processes in cells and tissues. Copper is located in a variety of enzymes important for detoxification such as superoxide dismutase which is active against reactive oxygen species. Other enzymes such as cytochrome c oxidase (involved in mitochondrial respiratory chain) and ceruloplasmin (ferroxidase enzyme participating in iron metabolism) also contain this element. In human body, copper absorption, distribution and excretion are strictly regulated, and conditions leading to its excess or deficiency are well-known. Recommendations for dietary intake may wary depending on several factors, but for healthy adults, the minimal intake suggested by the World health organization is approximately 1.3 mg/day [1] .
Copper nanoparticles, similarly as other nanoparticles have approximate diameter between 1 and 100 nanometers. Copper-based nanoparticles may include hybrid copper nanostructures, copper oxides, as well as different associations with other advanced materials and polymers. Nanoparticles made from bulk copper are relatively unstable in standard conditions because they tend to oxidize and lose the initial chemical and physical properties. Copper associated with other elements may be a more stable nanosystem, and the same is true with various copper-based NPs supported by carbon, metal oxides or silica.
Copper-based nanoparticles have wide industrial and engineering applications, predominantly as catalyst, sensing materials, part of superconductors, storage systems, and phototermal / thermoelectric materials. Copper oxide NPs may also serve as a valuable rocket propellant combustion catalyst. This all raises prospect of environmental contamination by these nanosystems. Therefore, possible effects of Cu-based nanomaterials on human and animal health is an issue definitely worthy of investigation [2] [3] [4] [5] [6] .
In recent years, there have been many indications that copper-based nanosystems may also have significant applications in biology and medicine. Potential antimicrobial activity and supposed use as biosensors for organic compound detection and measurement, have all contributed to extensive research of CuNPs by a number of world renown laboratories. If proven safe and nontoxic, CuNPs may be considered as part of promising diagnostic and therapeutic agents in many medical areas. Unfortunately many aspects of potential CuNPs toxicity remain unknown. In some circumstances and experimental conditions, hepatotoxic and nephrotoxic effects have indeed been observed, however, many of these results need to be confirmed by future studies. Neurotoxicity of these nanomaterials have also been the subject of several research endeavors. This concise review aims to cover recent research on potential CuNP toxicity, with the emphasis on neurotoxocity, nephrotoxicity and hepatotoxicity. Also, potential applications of CuNPs in fundamental and clinical medicine are discussed.
Potential copper nanoparticle neurotoxicity
Potential neurotoxicity of copper nanoparticles has been a subject of extensive research in recent years. However, despite these efforts, many issues remain unresolved, and today it is still not entirely clear if these nanoparticles, alone or in association with other nanosystems, have neurotoxic effects in conventional doses. Copper as a metal, when taken in excess as dietary supplement may exhibit some neurotoxicity. Also, there are diseases which in their pathophysiology have altered brain homeostasis of this element [7] . The example would be neurologic Wilson disease, a genetic, inherited condition characterized by a flaw in enzyme responsible for copper transportation. As a result, copper tends to accumulate in various tissues and organs, including the brain structures such as basal ganglia, thalamus and cortex. Alzheimer's disease, a chronic neurodegenerative disorder and frequent cause of dementia, may also be associated with significant changes (elevation or reduction) of copper levels in various brain areas [8] .
In terms of copper nanoparticles, it is still unclear to what extent they tend to accumulate in brain tissue. Nanoparticles in general can more easily pass through biological barriers, and taking this into account, it would be logical to assume that blood-brain barrier would not be a significant obstacle. Nevertheless, it is unclear if CuNPs, after entering biological fluids stay in nanoparticle form of turn to ions/other compounds. Also it is unclear if CuNPs may prefer one specific tissue to other in term of distribution, accumulation or elimination.
In recent years, there have been several efforts to test the potential CuNP neurotoxicity both in animal experimental models, an in in vitro conditions. In rats, in 2012, Trickler and associates investigated how CuNPs influence cerebral microvessel endothelial cells. The research has been performed on confluent rat brain microvessel endothelial cells (rBMECs). The authors found that CuNPs at high concentrations lead to secretion of prostaglandin E(2), TNF-α and IL-1β [9] . This release of proinflammatory mediators may indeed be one of the proposed neurotoxicity mechanisms in brain tissue. Two years later, in 2014 similar results on porcine brain microvessel endothelial cells have been obtained [10] .
Also in 2012, a team of Chinese scientists, performed experiments on rats, testing their spatial cognition, and performing an extensive histological and biochemic alanalysis of brain tissue [11] . The research revealed significant morphological and functional changes in rat hippocampus after exposure to nanoparticles of copper oxide. The changes were present in the long-term potentiation in regards to reduced slopes of field excitatory postsynaptic potentials. Possibly the most important finding is the increased generation of reactive oxygen species and malonaldehyde and decreased activities of superoxide dismutase and glutathione peroxidase [11] . This might indicate that CuNPs (in this case, copper oxide in nanoparticle form, CuONPs) exhibits their neurotoxic effects by oxidative stress mechanisms and increased production of free radicals. This wouldn't be the first occasion on which metallic nanoparticles or their compounds induce cytotoxic effects as the result of oxidative stress. There are numerous published works on silver, gold, iron and other metals that in nano-form exhibit toxicity through creation of reactive oxygen [12] [13] [14] [15] .
In mouse hippocampus, it is possible that by altering antioxidant mechanisms, and increasing the level of oxidative stress, CuO NPs may induce the programmed cell death. As demonstrated by Niska et al. [16] , in the mouse hippocampal HT22 cell line, exposure to CuO NPs may up-regulate certain pro-apoptotic genes such as Bax, and down-regulate genes involved in apoptosis prevention such as Bcl-2. This change in gene expression may be followed with the decreased activity of several important detoxification enzymes such as glutathione S-tranferase and superoxide dismutase [16] .
Finally, one of the most recent works on CuO toxicity in hippocampus is the one published by Li et al. [17] in which the authors demonstrated the negative impact of this nanomaterial on spatial cognition in rats. This is one of the rare research efforts to test the CuONP toxicity on an animal experimental model. The research showed the diminished learning and memory ability in rats (using Morris water maze test) following the exposure [17] . Also, the authors suggested the reduced glutamate transmission both presynapticly and postsynapticly, which in turn may have contributed to the efficiency of long-term potentiation in hippocampus.
Hepatotoxicity of copper nanoparticles
Liver is probably the most important organ involved in disposition and excretion of copper [18] . Copper from food passes through the liver, before becoming available for other organs and tissues. Copper as a metal, when overdosed (accidentally or intentionally) can be highly hepatotoxic, and both acute and chronic hepatotoxicity have so far been well described. Elevation of serum liver enzymes, jaundice, hepatic necrosis, and hepatic insufficiency may occur as the result. However, despite the relative abundance of data for hepatotoxicity of metallic (conventional) copper overdose, it is not well understood if copper nanoparticles have same effects, in similar concentrations. Research on this issue is not very frequent and in the future, additional studies will be needed to clarify it. When performing tests for CuNP hepatotoxicity, probably the most common approach is to measure the levels of liver serum enzymes followed by additional pathohistological analysis of the tissue [19] [20] [21] [22] [23] . The most commonly tested enzymes include alanine transaminase (ALT) and aspartate transaminase (AST), but others, such as alkaline phosphatase (ALP) and gamma-glutamyl transpeptidase (GGT) may also provide valuable data. Increased serum concentrations may indicate liver injury in terms of hepatocyte death resulting from direct toxic impact on the cell or indirectly as the result of bile obstruction. Other liver function tests that may be used when assessing CuNP effects may include measurement of bilirubin and albumin concentrations, alpha-fetoprotein (AFP), lactate dehydrogenase, ceruloplasmin, 5' nucleotidase, etc. Also, when doing research on laboratory animals, one might consider performing a full histological analysis of the liver tissue, searching for the signs of hepatic steatosis (buildup of fat), inflammation or hepatocyte necrosis [20, [24] [25] [26] .
One of the earliest researches of nano-sized copper particle-induced hepatotoxicity was probably one by Lei et al. [27] . In rats, after exposure to 200 mg/kg/d for 5 days, signs of scattered dot hepatocytic necrosis were noted. In the liver tissue, the main findings included increased concentrations of lactate and creatine and decreased concentrations of glutamine and taurine [27] . The authors proposed a theory that mitochondrial failure, changes in ketogenesis and fatty acid beta-oxidation were involved in pathogenesis of liver (and kidney) damage.
Scattered, dotted hepatocytic necrosis in rats was also noted in another work by Yang et al. [28] , as well as enzymes such as alanine aminotransferase and aspartate aminotransferase. Bile acid levels, total bilirubin and triglycerides were also increased after repeated nanocopper exposure for five days. The researchers also suggested that certain genes associated with oxidoreductase activity and signal transduction may have modulatory effect on this hepatotoxicity in rats [28] .
In 2013, Sizova and the associates suggested that programmed cell death might be one of the potential mechanisms of CuNP toxicity, not only in liver, but also in other organs and tissues. A large study done on 78 male Wistar rats demonstrated the existence of hepathotoxic effects at the CuNP dose of 6 mg/kg [29] . Using the expression of caspases and other methods, the authors also provided insight on cell readiness to apoptosis.
In another research in rats, Ibrahim et al. [30] found substantial morphological changes in liver, which were associated with changes in oxidant-antioxidant balance and increased concentrations of liver enzymes. This was additionally connected to marked DNA laddering, increased DNA fragmentation and changes in caspase-3 and Bax levels [30] . Interestingly, the authors described potentially protective impact of green tea extract which is known to have at least some antioxidant capacity.
Recently, in 2017, Khalaf and associates performed a very similar study on rats exposed to copper nanoparticles, and found significant increase in expression of apoptotic genes C-myc and C-jun. Apart from this finding, lipid peroxidation and induced nitric oxide were also elevated suggesting an additional mechanisms of hepatotoxicity [31] . An exogenous antioxidant, α-lipoic acid, had certain hepatoprotective effects in this study.
Finally, one should mention the recent work by Noureen et al. [32] in which the authors used a different animal model, Cyprinus carpio (a widespread freshwater fish). In the livers of fish exposed to copper nanoparticles elevated concentrations of lipid peroxide and reduced glutathione. Livers also showed extensive morphological damage such as, as the authors stated, "focal necrosis, cloudy swelling of hepatocytes, degenerative hepatocytes, vacuolization, pyknotic nuclei, damaged central vein, nuclear hypertrophy, dilated sinusoid, vacuolated degeneration, congestion and complete degeneration in a dose dependent manner" [32] . To the best of our knowledge, this is one of the most extensive and high quality research on histological/pathological changes in liver tissue following CuNP exposure.
Potential nephrotoxicity of copper nanoparticles
Considering the amount of available data on neurotoxic and hepatotoxic CuNP effects, nephrotoxicity is probably the least investigated. There are only a handful of studies published in recent years on this topic, and the research remains inconclusive on some aspects. This is somewhat expected, having in mind that most of the excess copper in the human body is excreted via bile/liver. Only a small amount of copper reaches and stays in the urine. Nevertheless, coper, in high concentrations can indeed have detrimental effects on urinary system. Potential nephrotoxicity of copper-based nanomaterials is unclear with very limited evidence present in current scientific literature. Possibly one of the most important studies on this issue is the one done by Liao and Liu (2012) in which male Wistar rats were administrate copper nanoparticles at doses of 50, 100 and 200 mg/kg. The study revealed significant and widespread renal proximal tubule necrosis. The authors also performed the whole genome transcriptome profiling of the organ and indicating that genes for oxidative phosphorylation, cell cycle, and metabolism of various substances (i.e. aminoacids) may be associated with kidney response to CuNPs [33] .
It is interesting that in porcine kidney cells, nanoparticles of copper may in certain conditions induce programmed cell death. As demonstrated in a recent study by Zhang et al. [34] , nano copper not only did induce apoptosis, but also changed membrane potential in mitochondria of PK-15 cell line. Genes involved in cell cycle and apoptosis such as Bax, Bid, Caspase-3, and CYCS had significantly altered expressions after exposure to nanoparticles [34] . The levels of malondialdehyde and superoxide dismutase (important in induction and management of oxidative stress) were also changed. It is possible that the similar chemical pathways / processes are involved in nephrotoxicity in living organisms, as suggested by the authors [34] .
Oxidative stress may indeed be one of the major pahthophysiological mechanisms in CuNP-induced nephrotoxicity, whereas, apoptosis is only a resulting consequence. As shown in the recent study by Khalid et al. [35] , antioxidant resveratrol has significant protective effects against copper oxide nanoparticle toxicity. The study was done in rats and both liver and kidney functions were investigated. The nanoparticle exposure led to the increase of creatinine and urea in serum indicating potential detrimental effects on kidney function [35] .
Concluding remarks
Although the research on the topic of CuNP toxicity is rather limited, the current evidence indicates the existence of neurotoxicity, hepatotoxicity and nephrotoxicity, at least in some experimental conditions and nanoparticle concentrations. This may be of some concern, especially in the field of public health, knowing that CuNPs have potentially wide industrial, engineering and medical applications. On the other hand, copper in its standard form, when overdosed, also exhibits significant toxicity. Biodistribution, accumulation and elimination of CuNPs is not entirely understood, as well as their ability to remain nanoparticles (diameter less than 100 nanometers) in body fluids.
In the future, several issues need to be resolved in order to enable full and safe use of copper nanoparticles in engineering and medical practice. First, interactions between CuNPs and many organic molecules need to be investigated. This is particularly true for potential damaging effect of CuNPs on DNA and the ability of CuNPs to interfere in intracellular signaling pathways and change the levels of gene expression. Second, the relationship between CuNP and generation of reactive oxygen species also needs to be clarified. From the currently available data, it seems oxidative stress resulting from CuNP exposure may be one of the most important mechanisms of cytotoxicity. Finally, extensive acute and chronic toxicity studies need to be performed on various animal experimental models. Only then, we may have enough valid data to make definite conclusions on copper nanoparticle toxicity and the potential implications in fundamental and clinical medicine.
NSF Center for Advanced Knowledge Enablement, Miami, FL, USA (I. Pantic is an external research associate).
